
Opinions
Cameron Hurst
Teva Pharmaceutical
TEVA-N
SELL
Dec 06, 2018
$20.260
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.